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Abstract
Introduction The demand for prophylactic mastectomy has increased significantly over the last 10 years. This can be 
explained by a substantial gain of knowledge about the clinical risk and outcome of patients with high risk mutations such 
as BRCA1 and 2, the improved diagnostic possibilities for detecting the genetic predisposition for the development of breast 
cancer and the awareness for those mutations by health care professionals as well as patients. In addition to expander-to-
implant reconstruction and microsurgical flap surgery, definitive immediate reconstruction with subpectoral insertion of 
breast implants is often preferred. The prosthesis is covered at its inferior pole by a synthetic mesh or acellular dermal 
matrix. In these cases, in addition to the silicone prosthesis, a further foreign body must be implanted. This can be exposed 
in the event of wound healing disorder or necrosis of the usually thin soft tissue covering after subcutaneous mastectomy, 
thus calling into question the reconstructive result. In this study, the coverage of the lower pole by a caudal deepithelialized 
dermis flap, which allows the implant to be completely covered with well vascularized tissue, is compared to coverage by a 
synthetic mesh or acellular dermal matrix.
Patients and methods From January 2014 to June 2020, 74 patients (106 breasts) underwent breast reconstruction follow-
ing uni or bilateral prophylactic mastectomy. Reconstruction was performed with autologous tissue (15 breasts), with tissue 
expander or implant without implant support (15 breasts), with implant and use of an acellular dermal matrix or synthetic 
mesh (39 breasts) and with implant and caudal dermis flap (37 breasts).
In this study, we compared the patients with implant and dermal matrix/mesh to the group reconstructed with implant and 
dermal flap.
Results In the group with the caudal dermis flap, 4 patients developed skin necrosis, which all healed conservatively due to 
the sufficient blood supply through the dermis flap. In the group with the use of a synthetic mesh or acellular dermal matrix, 
skin necrosis was found in three cases. In one of these patients the implant was exposed and had to be removed.
Discussion For patients with excess skin or macromastia, the caudal dermis flap is a reliable and less expensive option for 
complete coverage of an implant after prophylactic mastectomy. In particular, the vascularized dermis flap can protect the 
implant from the consequences of skin necrosis after prophylactic mastectomy.
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Introduction
Due to a substantial gain of knowledge about the clinical 
risk and outcome of patients with high risk mutations such 
as BRCA1 and 2, improved diagnostic possibilities for 
detecting the genetic predisposition for the development 
of breast cancer and the awareness for those mutations by 
health care professionals as well as patients, the demand 
for prophylactic mastectomy has increased significantly 
over the last 10 years. Many patients with breast cancer 
in their medical history ask for a genetic analysis. Gene 
mutations, for example in the BRCA1/BRCA2 gene, are 
frequently detected in this context [18]. Similarly, patients 
without a personal history of cancer but with a high famil-
ial risk of developing breast or ovarian cancer can be iden-
tified after investigations of mutation carriers in the family 
environment.
Even women without genetic modification increasingly 
want prophylactic mastectomy of the contralateral breast 
after breast cancer, although close follow-up in these 
women is equivalent to surgery in terms of long-term sur-
vival. As long as no additional potential risk of disease is 
seen in their familial environment, these patients are not 
encouraged to undergo contralateral prophylactic mastec-
tomy in accordance with the Contralateral Prophylactic 
Mastectomy (CPM) Consensus Statement of the American 
Society of Breast Surgeons [2,9].
The mean age of onset to develop breast cancer in 
women is in their sixth and seventh decade of life. Patients 
who consider a prophylactic mastectomy are on average 
much younger and more body-conscious, so that typically 
very high demands are placed on the reconstruction of the 
breast [11,14,17,20].
In addition to the classic procedures with a two-stage 
expander/implant reconstruction and autologous flaps, 
these patients often prefer immediate one-stage recon-
struction with a definitive anatomical implant. Synthetic 
meshes or acellular dermal matrices (ADM) are usually 
inserted to cover the subpectoral placed implant inferiorly 
[3,5,6,12,16]. In these cases, a further foreign body must 
be inserted in addition to the silicone prosthesis with the 
relevant risk of exposure in case of skin necrosis after 
subcutaneous mastectomy, potentially followed by failure 
of the complete reconstruction [1].
An alternative in patients with mild to severe ptosis mam-
mae or macromastia is the caudal dermis flap, which draws 
its blood supply from the subdermal vessels and is sutured 
to the caudal edge of the mobilized pectoralis major muscle 
[4]7. This ensures complete coverage of the implant with 
well-vascularized autologous tissue even before skin closure.
The study was approved and given informed consent by 
the local ethics committee.
Patients and methods
Between January 1, 2014 and March 31, 2020, 74 patients 
with a total of 106 breasts underwent prophylactic mastec-
tomy unilaterally or bilaterally at the University Breast Can-
cer Center Regensburg.
The following techniques have been used for 
reconstruction:
-Autologous DIEAP flap (uni-/ or bilateral Deep Inferior 
Epigastric Artery Perforator flap).
-Expander/Implant without additional support.
-Implant-based reconstruction with additional mesh/
ADM.
-Implant-based reconstruction with the caudal dermis 
flap.
All patients were operated on by a team of a plastic sur-
geon and an oncological gynecologist.
Indication
23 patients of the collective were carriers of a BRCA1 muta-
tion, 26 patients were carriers of a BRCA2 mutation. One 
patient each had Li-Fraumeni syndrome (TP53 mutation), 
CHEK2 mutation or ATM mutation. These mutations were 
regarded as pathogenic. In 3 women there was a familial 
accumulation of breast cancer without genetic mutation.
In 32 patients a bilateral prophylactic mastectomy was 
performed. 42 patients already had breast cancer in their 
history, so that a prophylactic mastectomy was performed 
contralateral to the breast cancer (Table 1).
Twelve patients (15 breasts) received a breast reconstruc-
tion with an autologous DIEAP flap.
In 62 patients (91 breasts) an implant-based reconstruc-
tion was performed. A single-stage implant-based, sub-
muscular immediate reconstruction after subcutaneous 
Table 1  Indications for prophylactic mastectomy





BRCA1 mutation 23 33
BRCA2 mutation 26 46
TP53 mutation 1 1
CHEK2 mutation 1 1
ATM mutation 1 1
Familial accumulation 3 5
Others 19 19
Contralateral breast cancer (unilat-
eral reconstruction)
42 42
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mastectomy was selected in 6 patients (7 breasts). In 7 
patients (8 breasts) a two-stage procedure with expander 
insertion and change to an anatomical implant was per-
formed 6 months later. In these two procedures, none of 
the 13 patients (15 breasts) received a caudal implant cover.
In 25 patients (39 breasts), caudal coverage of the subpec-
toral implant was performed as part of the immediate recon-
struction after subcutaneous mastectomy with a synthetic 
mesh or acellular dermal matrix (ADM). In total, a SERI 
mesh (Sofregen Medical Inc., Boston/USA) was used in 2 
patients (4 breasts). In 3 patients (5 breasts) a Vicryl mesh 
(Ethicon, USA) was inserted. In 20 patients (30 breasts) a 
bovine dermal matrix was used. Out of these, one patient (1 
breast) received a Surgimend matrix (Polytech, Germany), 
2 patients (4 breasts) Strattice and 17 patients (25 breasts) 
Artia (both LifeCell Corporation, Branchburg, New Jersey, 
USA).
In 24 patients (37 breasts), a vascularized caudal der-
mis flap was used to cover the lower pole of an anatomical 
implant during immediate reconstruction (Table 2).
In this study, only the implant-based reconstructions with 
caudal support by mesh/ADM or dermis flap were included. 
The aim of the study was to evaluate the safety and efficacy 
of the caudal dermis flap to cover the inferior pole of the 
implant compared to an implant-based reconstruction with 
coverage of the caudal pole by non-vascularized tissue (syn-
thetic mesh or ADM).
Surgical technique of the caudal dermis flap
Inclusion criteria for the technique have been patients 
with breast ptosis or macromastia, a nipple-IMF distance 
of 11 cm or more and a sternal-notch-to-nipple distance 
(SNND) of at least 25 cm (Figs. 1, 2).
A T-scar reduction figure was designed as a surgical 
access for prophylactic mastectomy, depending on the 
expected implant size. The caudal part of the skin was 
deepithelialized according to the Wise pattern [9]. Leaving 
an adipodermal flap of 5 mm of thickness in average with 
preservation of the subdermal vascular plexus, the gland was 
then removed from the fascia.
In 17 patients (28 breasts) the nipple-areola complex 
(NAC) was preserved on a medial pedicle. For natural con-
touring of the lower breast, the dermis was incised medially 
and laterally of the flap for about 2–3 cm to allow a tension-
free connection to the lower edge of the pectoralis muscle. 
Subcutaneous mastectomy was then performed, leaving the 
epipectoral fascia untouched.
The major pectoralis muscle was then lifted from its lat-
erocaudal margin and a subpectoral pocket was prepared. 
After subpectoral insertion of an appropriate anatomi-
cal implant, the caudal dermis flap with its free edge was 
sutured to the lower edge of the muscle. The asymmetrical 
shape of the dermis flap, which follows the shape of the 
"Wise pattern" with a larger portion laterally, corresponds to 
the deficit in coverage remaining caudolateral to the pectora-
lis muscle. Laterally, the serratus fascia was mobilized to the 
Table 2  Techniques of reconstruction





Autologous tissue (DIEAP) 12 15
Implant only 6 7
Expander only 7 8
Implant with synthetic mesh/ADM 25 39
Implant with caudal dermis flap 24 37
Fig. 1  Patient with ptosis grade 2 (BMI 21)
Fig. 2  Patient with ptosis grade 2 and asymmetry (BMI 18)
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anterior axillary fold to complete the coverage of the implant 
by suturing it to the margin of the lateral pocket (Fig. 3).
The skin flaps were now placed over the vascularized 
pocket and closed in two layers after insertion of a suction 
drainage. If the NAC had not been removed, it was rotated 
cranially on its medial pedicle, placed and sutured to the 
point of highest projection of the reconstructed breast.
To visualize the blood supply, an examination of the vas-
cularization with fluorescence imaging by administration 
of indocyanine green (IC-View, Novadaq/Stryker, Canada) 
was carried out in 19 operations after closure of the implant 
pocket, but before closure of the skin envelope. A lack of 
the blood supply at the skin envelope could be visualized 
at the same time and, if necessary, cured by local resection 
(DeVita R).
Results
In 74 patients who underwent prophylactic mastectomy 
between January 2014 and March 2020, a total of 106 
breasts were removed. Patients with cancer on the ipsilat-
eral side of the breast in their own medical history were not 
included in this study.
32 women had no history of breast cancer. In these cases, 
a bilateral prophylactic mastectomy was performed (64 
breasts). In 42 patients the contralateral side was treated for 
breast cancer (42 breasts).
The average BMI of all patients was 24 (18–33). The 
mean age was 41.6 years (22–64).
The minimum follow-up period was 6 months.
For this study, 49 patients (76 breasts) with implant-based 
reconstruction and caudal support were enrolled.
Based on the technique used, the patients were divided 
into two groups:
• Group A (submuscular implant with synthetic mesh or 
ADM)
• Group B (subpectoral implant with caudal dermis flap)
Group A included 25 patients (39 breasts) who received 
a caudal covering of the implant with an artificial mesh or 
ADM after subpectoral implant placement. The mean age 
of these patients was 38 years (24–58 years) and their BMI 
was 22.4 (19–27).
The nipple-areola complex was preserved in 19 patients 
(33 breasts).
An anatomical implant from Mentor was placed in six 
reconstructions. Reconstruction with a Polytech anatomical 
implant was performed 33 times. The volume of the implants 
varied between 210 and 610 cc, with an average of 380 cc.
Eleven patients had a history of contralateral breast 
cancer. Two of these patients had undergone contralat-
eral radiotherapy and seven had undergone chemotherapy. 
None of these pretreated women experienced postoperative 
complications.
Five patients of this group (8 breasts; 20.5%) were smok-
ers. In one of them a bilateral seroma was detected and 
treated (5.1%).
Three breasts had skin necrosis or deep wound healing 
disorder as complications (7.7%). As a result, in one patient 
the Vicryl net was exposed with consecutive implant loss 
(2.6%). The other two cases showed conservative healing of 
skin necrosis/wound healing disorder.
Severe scar deformation was observed in one patient as 
a minor complication (2.6%). One woman received a blood 
transfusion due to postoperative bleeding (2.6%).
Group B included 24 patients (37 breasts) with ptosis or 
macromastia. Thirteen patients in this group received bilat-
eral and eleven unilateral reconstructions. In all 37 recon-
structions, complete coverage of the implant was achieved 
by a caudal dermis flap, forming a closed, vascularized 
pocket (Figs. 4, 5). These patients were 43 years old on aver-
age (22–64). The BMI was 24.4 in average (19–33).
The nipple-areola complex was preserved in 17 patients 
(28 breasts).
Fig. 3  Bilateral caudal dermis flap intraoperatively
Fig. 4  Bilateral caudal dermis flap postoperatively (anatomical 
implants, 305 cc, NAC preserved)
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An anatomical implant from Mentor (Mentor LCC, 
Irvine, CA, USA) was selected for reconstruction in 14 
breasts. An anatomical implant from Polytech (Polytech 
Health & Aesthetics, Dieburg/Germany) was used for 23 
breasts. The implant volume ranged from 210 to 570 cc 
(average 400 cc).
Eleven patients in group B had a history of breast cancer. 
Ten women had received chemotherapy and five radiother-
apy of the contralateral breast. None of these patients had 
any complications.
Three patients were smokers (4 breasts, 10.8%). One of 
these patients developed skin necrosis.
The reconstruction did not fail in any case. A total of 
four breasts (10.8%) developed skin necrosis. These women 
healed conservatively in all cases.
In two patients a hematoma occurred postoperatively 
(5.4%). One of these hematomas required surgical revision 
(2.7%).
Looking at the whole collective in which a prophylac-
tic mastectomy was performed, skin necrosis occurred in 
12 breasts (11.3%). Within the two groups compared in the 
study, three cases of skin necrosis occurred after insertion 
of a synthetic mesh /ADM and four after use of the caudal 
dermis flap.
While all reconstructions with covering of the implant by 
caudal dermis flap were successful, implant reconstruction 
using a Vicryl mesh failed (implant loss after mesh 
exposure).
A total of eight patients (12 breasts) of the entire collec-
tive were smokers (11.3%). One of these patients developed 
skin necrosis after breast reconstruction with implant and a 
caudal dermis flap (8.3%). This could be healed conserva-
tively. Smoking was therefore not considered a relevant risk 
factor for skin lesions.
Seven patients of group A (28%) and ten women of group 
B (42%) hat received chemotherapy; none of them suffered 
skin lesions (Table 3).
Discussion
The goal of risk-reducing mastectomy is to remove healthy 
glandular tissue facing an increased risk of developing breast 
cancer. When planning a prophylactic operation, no consid-
eration must be given to a current tumor disease, so that a 
skin-sparing method is justified. The oncological safety of 
skin-saving procedures has been confirmed in many studies 
as well as by statements of the American Society of Breast 
Surgeons [13].
The preservation of the original skin envelope with simul-
taneous removal of the mammary gland in mostly younger, 
often slim patients poses a special challenge for the blood 
circulation of the remaining skin. In our study, 10.8% of 
the women with a caudal dermis flap suffered skin lesions 
or necrosis, which is quite similar to other series. Demiri 
[8] published results from fifty patients with 65 operated 
breasts and reconstruction with a caudal dermal flap, 16.9% 
of whom had skin lesions.
Gianotti et al. [10] were able to show that after mastec-
tomy, with an average thickness of the remaining skin enve-
lope of 5.5 mm, glandular tissue still remains on the skin in 
29.9% of operations. To remove the gland almost completely 
means a very intensive thinning of the skin envelope, accept-
ing a considerable risk of affecting the blood supply to the 
remaining skin.
Inbal et al. [11] could demonstrate that, according to the 
technique with the caudal dermis flap in addition to implant-
based reconstruction, resected breast weight above 700 g 
was associated with major complications significantly. In 
our study, only patients with prophylactic mastectomy and 
a resected breast weight lower than 700 g were compared.
Fig. 5  Bilateral caudal dermis flap postoperatively (anatomical 
implants, 320 cc, NAC removed)
Table 3  Complications after 
prophylactic mastectomy





Implant with synthetic mesh/ADM 3 1
(implant loss)
Implant with caudal dermis flap 4 0
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Potter et al. [15] had regarded 18% of revisions and 9% 
implant loss in a prospective multicenter study with 2655 
implant-based breast reconstructions.
Any necrosis of the skin carries the risk of exposure 
of the foreign material, with potential failure of the 
reconstruction. The use of autologous tissue, especially 
for bilateral reconstruction, is often limited in the men-
tioned target group of patients with the demand for pro-
phylactic surgery, so that from all prophylactic operations 
in our series, 86% of the interventions were performed 
implant-based.
While the mean BMI of the patients with autologous 
reconstruction after prophylactic mastectomy in our series 
was 28.3, patients with an implant-based reconstruction 
had a BMI of 23.3, so that the decision for the surgical 
procedure was also influenced by the patient`s weight and 
available donor regions.
For Vlajcic et al. [19], the caudal dermis flap reacts 
not only as a coverage of the lower pole but also as sus-
pension preventing laterocaudal sagging of the implant.
In patients with ptosis mammae or macromastia, the 
technique of the caudal dermis flap allows the implant 
to be placed in a completely vascularized pocket, before 
the skin envelope is closed [11]. The advantage of the 
caudal coverage of the implant with the dermis flap lays 
-next to the avoidance of an additional foreign body- in 
the protective effect of well-vascularized tissue before 
closing the skin envelope.
Our study demonstrates that skin necrosis, which 
potentially can lead to exposure of the deep layer and loss 
of reconstruction when using synthetic mesh or ADM, 
can heal conservatively due to adequate vascularization of 
the dermis flap. As a result, even in patients who are not 
eligible for a complete autologous tissue reconstruction, 
the caudal dermis flap achieves a higher safety to preserve 
the implant after skin necrosis by coverage of the implant 
with well-vascularized tissue.
In opposite to other studies [8], the overall complica-
tion rate was low in our series. Only one implant loss 
was registered following skin necrosis after insertion of 
a synthetic mesh.
Friedman et al. [9] published a technique, where the 
caudal dermis flap was used in combination with ADM. 
As a finding, the failure rate was significantly higher and 
the technical and economical effort was rising, so we 
don`t recommend the use of the dermis flap in combina-
tion with synthetic mesh or ADM.
Limitations of our study are the limited number of 
cases (39 vs. 37 breasts for the two compared groups) 
and the different inclusion criteria for the two groups 
(skin excess necessary for group B with the caudal der-
mis flap).
Conclusion
In our study of prophylactic mastectomy, we could demon-
strate that the vascularized caudal dermis flap is a reliable 
and safe alternative to cover the lower pole of a subpecto-
ral placed implant for patients with sufficient skin excess 
in case of macromasty or ptosis mammae.
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